Urology

 Current Trials

 Trial

 Urologic Problem

 Primary Investigator

Status

Safety of Biclutamide in Chemoprevention of Transitional Cell Carcinoma of the Bladder treated with BCG

 Bladder Cancer 

William See, MD

Open for enrollment

EDAP Ablatherm Integrated Imaging High Intensity Focused Ultrasound (HIFU) Indicated for Treatment of Low Risk, Localized Prostate Cancer

Prostate Cancer

Robert Donnell, MD

Closed to enrollment

A Randomized Double-Blind Parallel Group Study Comparing Casodex 50mg plus Placebo to Casodex 50mg plus dutasteride 3.5mg Administered for 18 months to Men with Prostate Cancer Who Have Failed First-Line Androgen Deprivation Therapy (Assessed by Rising PSA) Followed by a Two-Year Extension Phase

Prostate Cancer

Peter Langenstroer, MD

Closed to enrollment

A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 vs Bicalutamide in Castrate Men with Metastatic Prostate Cancer 

Prostate Cancer

Peter Langenstroer, MD

Pending IRB approval

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effectiveness of AA4500 Administered Two Times a Week for Up to Three Treatment Cycles (2 x 3) in Subjects With Peyronie’s Disease

Peyronies

Jon Pryor, MD

Closed to enrollment

A Multi-Center, Double-Blind, Placebo-Controlled Trial of Sanctura XR 60 mg Daily in Female OAB Patients on Multiple Concomitant Medications Refractory to Detrol LA 4 mg Daily

Overactive Bladder

Michael Guralnick, MD

Open for enrollment

Ex Vivo Thermoacoustic Imaging of Prostate Specimens for Cancer Localization

Prostate Cancer

Sarah Patch, PhD

Open for enrollment

MicroRNA Distribution along Human Nephrons Bank

Renal Cell Cancer

Mingyu Liang, PhD

Open for enrollment